Breaking News, Collaborations & Alliances, Trials & Filings

Trials & Filings: Oct. 15, 2013

Acacia, Atterocor, Endocyte, Helix, Insmed, Janssen-Cilag, Merck, Portola

By: Gil Roth

President, Pharma & Biopharma Outsourcing Association

Phase I Atterocor begins ACC trial . . . read more Helix reviews L-DOS47 results . . . read more Phase II Acacia reduces dry mouth . . . read more Insmed completes Arikace enrollment . . . read more Merck, Endocyte publish Vintafolide results . . . read more Portola posts results from Eliquis antidote . . . read more Filings Janssen-Cilag submits HIV-1 combo . . . read more...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters